MX6789E - Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol - Google Patents

Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol

Info

Publication number
MX6789E
MX6789E MX809191U MX919180U MX6789E MX 6789 E MX6789 E MX 6789E MX 809191 U MX809191 U MX 809191U MX 919180 U MX919180 U MX 919180U MX 6789 E MX6789 E MX 6789E
Authority
MX
Mexico
Prior art keywords
carboxipropioniloxietil
nitroimidazole
methyl
procedure
preparation
Prior art date
Application number
MX809191U
Other languages
English (en)
Spanish (es)
Inventor
Jose Juan Morales Roman
Jose Antonio Martinez Venegas
Original Assignee
Silanes Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silanes Lab filed Critical Silanes Lab
Priority to MX809191U priority Critical patent/MX6789E/es
Priority to PT74056A priority patent/PT74056B/pt
Priority to IT12688/81A priority patent/IT1145989B/it
Priority to BE//206684A priority patent/BE891284A/fr
Priority to LU83802A priority patent/LU83802A1/fr
Priority to CH7680/81A priority patent/CH652597A5/de
Priority to NL8105449A priority patent/NL8105449A/nl
Priority to FR8122594A priority patent/FR2494993A1/fr
Priority to GB8136309A priority patent/GB2089208A/en
Priority to DE19813147959 priority patent/DE3147959A1/de
Priority to JP56193768A priority patent/JPS57188518A/ja
Priority to CA000391456A priority patent/CA1184120A/en
Publication of MX6789E publication Critical patent/MX6789E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX809191U 1980-12-03 1980-12-03 Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol MX6789E (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
MX809191U MX6789E (es) 1980-12-03 1980-12-03 Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol
PT74056A PT74056B (en) 1980-12-03 1981-11-27 Process for preparing pharmaceutical compositions containing 1--(2-3'-carboxypropionil oxyethyl)-2-methyl-5-nitroimidazole as active therapeutic agent against diseases caused by anaerobic germs
IT12688/81A IT1145989B (it) 1980-12-03 1981-11-27 Composto farmaceutico contenente 1.2.3.carbossipropionil ossietile 2 metile 5 nitroimidazolo quale a gente terapeutico attivo contro le malattie causate da germi anaerobi
BE//206684A BE891284A (fr) 1980-12-03 1981-11-30 Compositions pharmaceutiques contenant du 1-(2-3'-carboxypropionyl oxythyl) 2-methyl!5-nitroimidazole ou ses sels, en tant qu'agents therapeutiques actifs contre les maladies provoquees par des germes anaerobies
LU83802A LU83802A1 (fr) 1980-12-03 1981-12-01 Compositions pharmaceutiques contenant du 1-(2-3'-carboxypropionyl oxyethyl)2-methyl-5-nitroimidazole ou ses sels,en tant qu'agents therapeutiques actifs contre les maladies provoquees par des germes anaerobies
CH7680/81A CH652597A5 (de) 1980-12-03 1981-12-01 Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol.
NL8105449A NL8105449A (nl) 1980-12-03 1981-12-02 Farmaceutische preparaten, die 1-(2,3'-carboxypropionyloxyethyl)-2-methyl-5-nitroimidazol als actief bestanddeel bevatten als geneesmiddel tegen door anaerobe microoerganismen veroorzaakte ziekten.
FR8122594A FR2494993A1 (fr) 1980-12-03 1981-12-02 Compositions pharmaceutiques contenant du 1-(2-3'carboxypropionyl oxyethyl)-2-methyl-5-nitroimidazole ou ses sels, en tant qu'agents therapeutiques actifs contre les maladies provoquees par des germes anaerobies
GB8136309A GB2089208A (en) 1980-12-03 1981-12-02 Antibacterial compositions containing 1-(2,3'-carboxypropionyl oxyethyl)-2-methyl-5-nitroimidazole
DE19813147959 DE3147959A1 (de) 1980-12-03 1981-12-03 Pharmazeutische zusammensetzung, die 1- 2-(3'-caroxypropionyl)oxyethyl -2-methyl-5-nitroimidazol als therapeutischen wirkstoff gegen erkrankungen enthaelt, die von anaeroben bakterien verursacht sind
JP56193768A JPS57188518A (en) 1980-12-03 1981-12-03 Medicinal composition and preventive composition
CA000391456A CA1184120A (en) 1980-12-03 1981-12-03 Pharmaceutical composition containing 1-(2-3'- carboxypropionyl oxyethyl)-2-methyl-5-nitroimidazole as active therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX809191U MX6789E (es) 1980-12-03 1980-12-03 Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol

Publications (1)

Publication Number Publication Date
MX6789E true MX6789E (es) 1986-07-21

Family

ID=19741552

Family Applications (1)

Application Number Title Priority Date Filing Date
MX809191U MX6789E (es) 1980-12-03 1980-12-03 Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol

Country Status (12)

Country Link
JP (1) JPS57188518A (nl)
BE (1) BE891284A (nl)
CA (1) CA1184120A (nl)
CH (1) CH652597A5 (nl)
DE (1) DE3147959A1 (nl)
FR (1) FR2494993A1 (nl)
GB (1) GB2089208A (nl)
IT (1) IT1145989B (nl)
LU (1) LU83802A1 (nl)
MX (1) MX6789E (nl)
NL (1) NL8105449A (nl)
PT (1) PT74056B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194283B (it) * 1983-06-21 1988-09-14 Isnardi Pietro & C Spa Derivato idrosolubile del 1-(2-idrossietil)-2-metil-5-nitro-imidazolo ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
AU9134791A (en) * 1990-12-11 1992-07-08 Brocades Pharma B.V. Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB983123A (en) * 1961-07-07 1965-02-10 Rhone Poulenc Sa Improvements in or relating to imidazole derivatives

Also Published As

Publication number Publication date
FR2494993A1 (fr) 1982-06-04
PT74056B (en) 1983-04-26
DE3147959A1 (de) 1983-03-24
CA1184120A (en) 1985-03-19
LU83802A1 (fr) 1983-09-01
GB2089208A (en) 1982-06-23
JPS57188518A (en) 1982-11-19
PT74056A (en) 1981-12-01
IT1145989B (it) 1986-11-12
NL8105449A (nl) 1982-07-01
CH652597A5 (de) 1985-11-29
IT8112688A0 (it) 1981-11-27
BE891284A (fr) 1982-06-01

Similar Documents

Publication Publication Date Title
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES511498A0 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
AR225794A1 (es) Un procedimiento para la preparacion de 2-(2-(1,4-benzodioxanil))-2-imidazolina
ES512913A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
ES502429A0 (es) Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina
ES537343A0 (es) Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES504503A0 (es) Procedimiento para la preparacion de 3-bencilsulfonil-1-die-tilcarbamoil-1,2,4-triazol
ES501432A0 (es) Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias.
ES501077A0 (es) Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
AR227697A1 (es) Procedimiento para la preparacion de 3,4-bis-sustituido 1,2,5,-oxadiazol-2-oxidos
ES509131A0 (es) "un procedimiento para la preparacion de un derivado de imidazolina".
ES500618A0 (es) Procedimiento para la preparacion de 2,3-dicloro-2-trifluo- rometil-1,1,1,3,4,4,5,5,5,-nonafluoropentano
ES516413A0 (es) "procedimiento para la preparacion de un polimero".
MX7052E (es) Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas
ES509761A0 (es) "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas".
ES497342A0 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido
ES517471A0 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
MX6789E (es) Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol
AR231981A1 (es) Procedimiento para la preparacion de 1-(1,3-benzodioxol-5-il)-2-pirrolidinona
ES508723A0 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".
ES514224A0 (es) "procedimiento para la preparacion de 2,4-diamino-(3,5-dimetoxi-4-metoxietoxibenzil)-pirimidina".
ES505478A0 (es) Procedimiento para la preparacion de 2,5-dimetilhexadieno-2,4
ES498876A0 (es) Procedimiento para preparar compuestos de anillos heteroci- clicos 2,2,6,6-tetrametil-4-pireridil-sustituidos